Sevoflurane for general anaesthetic management in a patient with Larsen syndrome.
D000015:Abnormalities, Multiple; D000768:Anesthesia, General / Q000379:methods*; D018685:Anesthetics, Inhalation / Q000627:therapeutic use; D002675:Child, Preschool; D005145:Face / Q000002:abnormalities*; D005260:Female; D006351:Heart Valves / Q000002:abnormalities; D006552:Hernia, Inguinal / Q000601:surgery; D006801:Humans; D007592:Joint Diseases / Q000151:congenital*; D004204:Joint Dislocations / Q000151:congenital*; D007828:Laryngoscopy; D008738:Methyl Ethers / Q000627:therapeutic use*; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use; D009609:Nitrous Oxide / Q000627:therapeutic use; D010027:Osteotomy; D010100:Oxygen / Q000627:therapeutic use; D000077149:Sevoflurane; D013577:Syndrome; D014673:Vecuronium Bromide / Q000627:therapeutic use
D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D003473:Neuromuscular Nondepolarizing Agents; D000077149:Sevoflurane; D014673:Vecuronium Bromide; D009609:Nitrous Oxide; D010100:Oxygen